ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38530; 2) Community: the network communities that were significantly associated with the response to NSC 38530; 3) Molecule: the relationships between components within communities and NSC 38530; 4) MDR: the compounds that were significantly associated with the NSC 38530.

NSC Compound Enrichment Correlation
NSC 287459 Cytarabine AY 0.0268790882218883 0.25424288
NSC 329127 Null 0.0268790882218883 0.62402605
NSC 35580 Null 0.0268790882218883 0.32304201
NSC 678156 Null 0.0268790882218883 0.25544906
NSC 102627 Yoshi 864 0.0286383688883668 0.051362713
NSC 150094 1-Azabicyclo[2.2.2]octan-3-one, 2-(4-morpholinylmethyl)- 0.0286383688883668 0.81191818
NSC 153325 Null 0.0286383688883668 0.52743038
NSC 175630 Toyocamycin, 6-amino- 0.0286383688883668 0.54038492
NSC 237677 Null 0.0286383688883668 0.68363185
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0286383688883668 -0.26451184
Total:84  Current:53    [First] [Prev] [Next] [Last]